comprehensive -WSS

comprehensive

author：explore 2025-10-01 12:35:43 - browse：4

Eli Lilly headquarters in Indianapolis – pharmaceutical coverage from STAT — Darron Cummings/AP

The blockbuster weight loss and diabetes drug sold by Eli Lilly also appears to improve fatty liver disease, according to early clinical trial data the pharmaceutical company released Tuesday.

Eli Lilly reported during its fourth-quarter earnings call that tirzepatide, which is sold commercially as Mounjaro or Zepbound, succeeded in a Phase 2 test as a treatment for the liver disease MASH. Around 74% of adults in the trial taking the drug were free of MASH after 52 weeks, compared to approximately 13% of the placebo group.

MASH, formerly known as NASH, is a liver disease characterized by excess fat and inflammation. The chronic inflammation can also lead to liver scarring, or fibrosis.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： United colonoscopy coverage change 'may cost lives,' doctors say
Next article： Alzheimer's risk factor APOE4 may be a distinct form of the disease

WSS

Alzheimer's risk factor APOE4 may be a distinct form of the disease

Laying a path for careers in science

Study fuels hope CAR

Drug companies' payments and gifts affect physicians' prescribing

Ohio train derailment: Experts on toxic chemical risks

Gut bacteria may contribute to kidney autoimmunity, study finds

leisure time

comprehensive

focus

Duchenne breakthrough therapy leaves behind pioneering families

Bird flu in dairy cattle: New measures to control spread to humans

Drug repurposing or repositioning? The language matters

Medicare isn't yet testing food as medicine

Walensky prepares to leave CDC — and Congress — behind

Doctor of U.S. President Joe Biden says he is fit for duty

Walensky prepares to leave CDC — and Congress — behind

Elisabeth Bik tackles the widespread issue of research misconduct

Trump demands the U.S. pay no more for drugs than other countries … again

CDC panel: People 65 and older should get a Covid spring booster shot

focus

First Opinion on colorectal cancer screening: letter and response

'Vaccine

Study fuels hope CAR

Florida Supreme Court upholds state's abortion ban

Color Health wants to make cancer screenings convenient

Oral obesity drug from Viking Therapeutics hits key early target

focus

hotspot

entertainment

leisure time